Skip to main content

Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved | Benzinga

By December 31, 2018News
2018-year-1-pixa

2018-year-1-pixa

Health care stocks are among a handful of sectors bucking the broader market downturn in 2018. Biotechs, though down for the year, have suffered less damage than other stocks.

{iframe}https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12859122/biotechs-were-innovators-in-2018-here-are-the-top-new-m{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.